Skip to main content
OpenTrials

Clinical trial condition

Kidney Diseases

Explore clinical trials studying Kidney Diseases. Study availability and eligibility vary by location and protocol.

8,805 public trials 1,412 recruiting studies
Refine in advanced search Browse all conditions

Kidney Diseases trial results

Active, Not Recruiting

A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

NCT04195750

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Faculty Office Towers 1132 ( Site 1538) Birmingham, Alabama, United States
  • University of California San Diego Moores Cancer Center ( Site 1546) La Jolla, California, United States
  • St. Joseph Heritage Healthcare Local Lab ( Site 1531) Santa Rosa, California, United States
  • University of Colorado Cancer Center ( Site 1540) Aurora, Colorado, United States
View all 172 locations
View Trial Details
Active, Not Recruiting

Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial

NCT05411081

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 199 locations
View Trial Details
Active, Not Recruiting

Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

NCT02496208

Conditions
Adenocarcinoma, Bladder Small Cell Neuroendocrine Carcinoma, Bladder Squamous Cell Carcinoma, +54 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View Trial Details
Active, Not Recruiting

A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma

NCT05805501

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC Irvine Medical Center Orange, California, United States
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
View all 44 locations
View Trial Details

Related conditions